By midafternoon, shares had dropped 4% to $9.86.
Over the three months to April, the company generated $1.05 billion in revenue, a 2.8% year-over-year decrease. Analysts surveyed by Thomson Reuters had expected sales of $1.1 billion. Net losses of 9 cents a share were wider than a 4-cents-a-share net loss analysts had forecast.
TheStreet Ratings team rates UTI WORLDWIDE INC as a Sell with a ratings score of D+. TheStreet Ratings Team has this to say about their recommendation:
"We rate UTI WORLDWIDE INC (UTIW) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, generally disappointing historical performance in the stock itself and poor profit margins."
- You can view the full analysis from the report here: UTIW Ratings Report